Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Map Syndrome”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableLooking for participantsNCT07383220
What this trial is testing

Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure

Who this might be right for
Resistant HypertensionHemodynamic InstabilityEssential (Primary) Hypertension+5 more
Mohamed Mohamed Ali Morgan 50
Not applicableStudy completedNCT01752296
What this trial is testing

Psychological Concomitants of Morquio Syndrome (The MAP Study)

Who this might be right for
Morquio DiseaseMucopolysaccharidosis IV
Nadia Ali, PhD 20
Not applicableLooking for participantsNCT07015203
What this trial is testing

The Combined First Trimester Screening

Who this might be right for
Preeclampsia (PE)Fetal Growth RestrictionCongenital Abnormalities+4 more
Institute of Health Information and Statistics of the Czech Republic 2,000
Testing effectiveness (Phase 2)Study completedNCT00113893
What this trial is testing

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Who this might be right for
Bone Marrow DiseasesMyelodysplastic SyndromesHematologic Diseases+1 more
Scios, Inc. 62
Not applicableNo Longer AvailableNCT04498871
What this trial is testing

MAP to Provide Access to Nilotinib, for Patients With HES

Who this might be right for
Hypereosinophilic Syndrome (HES)
Novartis Pharmaceuticals
Not applicableStudy completedNCT02198092
What this trial is testing

Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes

Who this might be right for
Familial Adenomatous PolyposisMap SyndromeLynch Syndrome+2 more
University of Pennsylvania 24
Not applicableEnded earlyNCT03582046
What this trial is testing

Targeting Abdominal Perfusion Pressure in Septic Shock

Who this might be right for
Acute Kidney InjurySeptic ShockResuscitations
Potrero Medical 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07498426
What this trial is testing

Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Who this might be right for
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals 300
Not applicableAvailableNCT05222412
What this trial is testing

Managed Access Programs for LNP023, Iptacopan

Who this might be right for
C3 Glomerulopathy (C3G)Paroxysmal Nocturnal Hemoglobinuria (PNH)
Novartis Pharmaceuticals
Large-scale testing (Phase 3)WithdrawnNCT02069288
What this trial is testing

Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock

Who this might be right for
Septic Shock
Rennes University Hospital
Not applicableStudy completedNCT00001642
What this trial is testing

Positional Cloning of the Gene(s) Responsible for Alagille Syndrome

Who this might be right for
Alagille Syndrome
National Human Genome Research Institute (NHGRI) 225
Post-approval studies (Phase 4)Study completedNCT02085291
What this trial is testing

Effect of Different Strategies for Titrating a High MAP on Microcirculation

Who this might be right for
Septic ShockHypertension
Southeast University, China 24
Not applicableEnded earlyNCT01473498
What this trial is testing

Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock

Who this might be right for
Septic ShockAcute Kidney Injury
Assistance Publique - Hôpitaux de Paris 27
Post-approval studies (Phase 4)UnknownNCT02489864
What this trial is testing

The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure

Who this might be right for
Hepatorenal Syndrome
Sun Yat-sen University 30
Post-approval studies (Phase 4)Study completedNCT02519699
What this trial is testing

Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension

Who this might be right for
Septic Shock
Federal University of São Paulo 40
Testing effectiveness (Phase 2)Study completedNCT01242462
What this trial is testing

Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial

Who this might be right for
Respiratory Distress Syndrome, Newborn
University of Alabama at Birmingham 12
Not applicableStudy completedNCT03824366
What this trial is testing

Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy

Who this might be right for
MalignancyMetastasisHemoptysis+4 more
Washington University School of Medicine 20
Not applicableStudy completedNCT06953297
What this trial is testing

Vasopressin Use in Septic Shock From Türkiye

Who this might be right for
Septic ShockVasodilatory ShockCritical Illness Sepsis, Severe+3 more
Karadeniz Technical University 146
Not applicableAvailableNCT07244289
What this trial is testing

Managed Access Programs for VAY736, Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaSjögren's Syndrome
Novartis Pharmaceuticals
Not applicableUnknownNCT04136080
What this trial is testing

The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock

Who this might be right for
Septic Shock
Fujian Provincial Hospital 752
Load More Results